305 related articles for article (PubMed ID: 26587828)
1. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors.
Pinheiro C; Granja S; Longatto-Filho A; Faria AM; Fragoso MC; Lovisolo SM; Lerário AM; Almeida MQ; Baltazar F; Zerbini MC
Oncotarget; 2015 Dec; 6(42):44403-21. PubMed ID: 26587828
[TBL] [Abstract][Full Text] [Related]
2. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
[TBL] [Abstract][Full Text] [Related]
3. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Kim Y; Choi JW; Lee JH; Kim YS
Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
[TBL] [Abstract][Full Text] [Related]
4. GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior.
Pinheiro C; Granja S; Longatto-Filho A; Faria AM; Fragoso MCBV; Lovisolo SM; Bonatelli M; Costa RFA; Lerário AM; Almeida MQ; Baltazar F; Zerbini MCN
Oncotarget; 2017 Sep; 8(38):63835-63845. PubMed ID: 28969033
[TBL] [Abstract][Full Text] [Related]
5. CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.
Alves WEFM; Bonatelli M; Dufloth R; Kerr LM; Carrara GFA; da Costa RFA; Scapulatempo-Neto C; Tiezzi D; da Costa Vieira RA; Pinheiro C
BMC Cancer; 2019 Dec; 19(1):1173. PubMed ID: 31795962
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder.
Choi JW; Kim Y; Lee JH; Kim YS
Urology; 2014 Jul; 84(1):245.e9-15. PubMed ID: 24857275
[TBL] [Abstract][Full Text] [Related]
7. Analysis of histological and immunohistochemical patterns of benign and malignant adrenocortical tumors by computerized morphometry.
Dalino Ciaramella P; Vertemati M; Petrella D; Bonacina E; Grossrubatscher E; Duregon E; Volante M; Papotti M; Loli P
Pathol Res Pract; 2017 Jul; 213(7):815-823. PubMed ID: 28554744
[TBL] [Abstract][Full Text] [Related]
8. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
[TBL] [Abstract][Full Text] [Related]
9. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
[TBL] [Abstract][Full Text] [Related]
10. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
Kock L; Mahner S; Choschzick M; Eulenburg C; Milde-Langosch K; Schwarz J; Jaenicke F; Müller V; Woelber L
Int J Gynecol Cancer; 2011 Jan; 21(1):141-8. PubMed ID: 21330838
[TBL] [Abstract][Full Text] [Related]
11. The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4.
Pinheiro C; Miranda-Gonçalves V; Longatto-Filho A; Vicente AL; Berardinelli GN; Scapulatempo-Neto C; Costa RF; Viana CR; Reis RM; Baltazar F; Vazquez VL
Cell Cycle; 2016 Jun; 15(11):1462-70. PubMed ID: 27105345
[TBL] [Abstract][Full Text] [Related]
12. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.
Pennanen M; Heiskanen I; Sane T; Remes S; Mustonen H; Haglund C; Arola J
Hum Pathol; 2015 Mar; 46(3):404-10. PubMed ID: 25582500
[TBL] [Abstract][Full Text] [Related]
13. Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness.
Parviainen H; Schrade A; Kiiveri S; Prunskaite-Hyyryläinen R; Haglund C; Vainio S; Wilson DB; Arola J; Heikinheimo M
Pathol Res Pract; 2013 Aug; 209(8):503-9. PubMed ID: 23866946
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.
Yamazaki Y; Nakamura Y; Shibahara Y; Konosu-Fukaya S; Sato N; Kubota-Nakayama F; Oki Y; Baba S; Midorikawa S; Morimoto R; Satoh F; Sasano H
Hum Pathol; 2016 Jul; 53():41-50. PubMed ID: 26980031
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma.
Mete O; Gucer H; Kefeli M; Asa SL
Am J Surg Pathol; 2018 Feb; 42(2):201-213. PubMed ID: 28877067
[TBL] [Abstract][Full Text] [Related]
17. Adrenocortical tumors in Brazilian children: immunohistochemical markers and prognostic factors.
Sbragia L; Oliveira-Filho AG; Vassallo J; Pinto GA; Guerra-Junior G; Bustorff-Silva J
Arch Pathol Lab Med; 2005 Sep; 129(9):1127-31. PubMed ID: 16119984
[TBL] [Abstract][Full Text] [Related]
18. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
[TBL] [Abstract][Full Text] [Related]
19. The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.
Duregon E; Fassina A; Volante M; Nesi G; Santi R; Gatti G; Cappellesso R; Dalino Ciaramella P; Ventura L; Gambacorta M; Dei Tos AP; Loli P; Mannelli M; Mantero F; Berruti A; Terzolo M; Papotti M
Am J Surg Pathol; 2013 Sep; 37(9):1433-40. PubMed ID: 23774167
[TBL] [Abstract][Full Text] [Related]
20. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]